The Motley Fool··Prosper Junior BakinyBristol Myers Squibb's Patent Cliff Concerns Masked by Attractive Valuation
Bristol Myers Squibb trades at a 46% discount to sector averages despite patent cliff concerns, offering attractive valuation and 4.5% yield for long-term investors.
BMYCELGrJNJBNTXvaluationdividend yield